Altium Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-119,526
| Closed | -$1.76M | – | 69 |
|
|
2023
Q4 | $1.76M | Sell |
119,526
-415,174
| -78% | -$6.11M | 1.19% | 23 |
|
|
2023
Q3 | $9.79M | Buy |
534,700
+349,700
| +189% | +$6.4M | 5.11% | 5 |
|
|
2023
Q2 | $3.99M | Hold |
185,000
| – | – | 3.02% | 12 |
|
|
2023
Q1 | $5.43M | Buy |
185,000
+45,000
| +32% | +$1.32M | 3.01% | 5 |
|
|
2022
Q4 | $5.17M | Buy |
140,000
+105,000
| +300% | +$3.88M | 2.63% | 10 |
|
|
2022
Q3 | $985K | Buy |
+35,000
| New | +$985K | 0.36% | 83 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 122 |
|